Skip directly to content

MedWorm Liver Transplant

Subscribe to MedWorm Liver Transplant feed
MedWorm.com provides a medical RSS filtering service. Thousands of medical RSS feeds are combined and output via different filters. This feed contains the latest news in Liver Transplant
Updated: 30 min 52 sec ago

Johns Hopkins seeks to join Greater Washington transplant competition

Wed, 05/24/2017 - 14:44
Suburban Hospital wants to create a liver transplant center at its expanding Bethesda campus, joining a growing number of health systems nationally seeking to add the service line. Johns Hopkins Health System, Suburban's owner, having invested in hepatology services for liver disease patients in the D.C. region for the past two years, has seen a demonstrated need for additional prevention and treatment services. "While disease prevention or effective treatments to arrest th e progress of disease… (Source: bizjournals.com Health Care News Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Categories: Publications

World's leading liver experts focus on continuing advancements in liver disease & transplantation

Wed, 05/24/2017 - 03:00
(Intermountain Medical Center) As the prevalence of liver disease continues to rise across the world, the growing number of people impacted by cirrhosis, liver cancer, and nonalcoholic fatty liver disease, is the focus of more than 1,700 of the world's leading liver disease experts. (Source: EurekAlert! - Infectious and Emerging Diseases)
Categories: Publications

HBIG Plus Antivirals May Prevent HBV Reinfection After Transplant HBIG Plus Antivirals May Prevent HBV Reinfection After Transplant

Mon, 05/22/2017 - 19:22
A very short course of hepatitis B immunoglobulin (HBIG) after liver transplantation, along with long-term antiviral therapy, may prevent hepatitis B virus (HBV) reinfection, a retrospective study suggests.Reuters Health Information (Source: Medscape Transplantation Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Categories: Publications

Specialist in organ transplantation appointed inaugural Paul I. Terasaki Chair in Surgery

Thu, 05/18/2017 - 23:01
UCLADr. Jerzy Kupiec-WeglinskiDr. Jerzy Kupiec-Weglinski has been appointed the inaugural Paul I. Terasaki Chair in Surgery at UCLA. Kupiec-Weglinski is a professor of surgery, pathology and laboratory medicine. He is the  vice chairman of basic science research in the department of surgery and director of the Dumont-UCLA Transplantation Research Laboratories in the division of liver and pancreas transplantation.His career in experimental organ transplantation spans more than  35 years. After graduating from medical school in Warsaw and obtaining his Ph.D. in the Polish Academy of Sciences, Kupiec-Weglinski spent 18 years at the Surgical Research Laboratories, Brigham and Women’s Hospital, and was an associate professor of surgery at Harvard Medical School. Since co ming to the div...

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Categories: Publications

FDA panel recommends approval for TransMedics lung transplant device

Thu, 05/18/2017 - 15:54
An FDA advisory panel yesterday recommended that the federal safety watchdog approve a device made by TransMedics to keep donated lungs perfused during transport to transplantation procedures. The FDA’s Gastroenterology & Urology Devices panel voted 11-2 that the OCS Lung system is safe; 8-5 that it’s effective; and 9-4 that its benefits outweigh the risks, an FDA spokeswoman told MassDevice.com via email. TransMedics did not respond to a request for comment. A previously scheduled advisory panel hearing for another TransMedics device, the OCS Heart system, was cancelled by the FDA in November 2015. The agency told MassDevice.com at the time that “FDA has determined that an advisory committee is no longer needed to discuss the premarket approval application&#822...
Categories: Publications

What Causes Anemia?

Sun, 05/14/2017 - 23:29
Discussion One of the most common problems in pediatrics is anemia. It is defined as “a lower than normal value for the related measurements of hemoglobin, hematocrit, and number of red blood cells”, usually 2 standard deviations below the normal for age. Normal hematological values change with age. For a discussion of which values are used click here. The most common type of anemia in childhood is iron deficiency which is commonly caused by inadequate stores (e.g. premature infant), inadequate intake (e.g. poor nutrition) or blood loss (e.g. menses). Anemia screening is recommended at age 9-12 months, and for adolescent males and females during routine health examinations. As iron deficiency is the most common cause, often a trial of therapeutic iron (2-6 mg/kg/day of element...

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Categories: Publications

New pill spares women trauma of liver transplant

Sat, 05/13/2017 - 20:17
In the UK, 20,000 people – 90 per cent of them women – suffer from primary biliary cholangitis, also known as primary biliary cirrhosis (PBC). (Source: the Mail online | Health)
Categories: Publications

FDA Drug Safety Communication: FDA limits duration and usage of Samsca (tolvaptan) due to possible liver injury leading to organ transplant or death

Fri, 05/12/2017 - 14:04
The U.S. Food and Drug Administration (FDA) has determined that the drug Samsca (tolvaptan) should not be used for longer than 30 days and should not be used in patients with underlying liver disease because it can cause liver injury, potentially requiring liver transplant, or death. (Source: FDA Center for Drug Evaluation and Research - What's New)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Categories: Publications

Liver Transplant Outcomes Improve Over Time (CME/CE)

Tue, 05/09/2017 - 16:00
(MedPage Today) -- Patient, graft survival higher following introduction of new HCV drugs (Source: MedPage Today Gastroenterology)

MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best Christmas presents too.

Categories: Publications

Gene Variation Predicts Recovery in Decompensated Hep C Gene Variation Predicts Recovery in Decompensated Hep C

Sun, 05/07/2017 - 15:46
Genetic differences that are associated with recovery in patients with hepatitis C and decompensated cirrhosis who achieve a sustained virologic response could someday guide liver transplantation.Medscape Medical News (Source: Medscape Medical News Headlines)

MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best Christmas presents too.

Categories: Publications

Study: Genetic markers may predict which HCV, cirrhosis patients improve with treatment

Sat, 05/06/2017 - 03:00
This study was presented at Digestive Disease Week ® (DDW) 2017, the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. (Source: EurekAlert! - Medicine and Health)
Categories: Publications

Multiclass HCV Resistance to DAA Failure Multiclass HCV Resistance to DAA Failure

Tue, 05/02/2017 - 03:16
This study aimed to define the pattern of clinically relevant resistance-associated substitutions associated with real-life DAA virological failures.Liver International (Source: Medscape Transplantation Headlines)

MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best Christmas presents too.

Categories: Publications

Milestones made possible #becauseofadonor

Mon, 05/01/2017 - 11:58
There are more than 80 children currently waiting for life-saving organ transplants at Boston Children’s Hospital. The Pediatric Transplant Center team is grateful for the donors who give these kids a second chance. Meet Maggie. The 20-year-old received her first double-lung transplant at 4 years old and her second at 7 years old. #becauseofadonor, Maggie is able to go to college. Meet Tom. At 15 years old, he received a liver transplant. #becauseofadonor, Tom, now 22, is able to run the Boston Marathon. Meet Aaron. The 10-year-old received his heart transplant at just 1 year old. #becauseofadonor, Aaron was able to get his black belt in karate. Tell us about your milestone made possible #becauseofadonor. The post Milestones made possible #becauseofadonor appeared first on Th...
Categories: Publications

WATCH: Baby boy finds 'perfect' liver match in godmother

Fri, 04/28/2017 - 16:22
Their emotional meeting after the transplant operation that saved Finn O'Sullivan's life. (Source: ABC News: Health)
Categories: Publications

Fecal Transplant Safe for Hepatic Encephalopathy Fecal Transplant Safe for Hepatic Encephalopathy

Thu, 04/27/2017 - 18:19
For the first time, a clinical trial has shown that fecal transplantation can ease the decline in brain function that can result from liver failure; and the effectiveness surprised researchers.Medscape Medical News (Source: Medscape Critical Care Headlines)
Categories: Publications

New progress toward finding best cells for liver therapy

Wed, 04/26/2017 - 12:54
In an important step toward using transplanted cells to treat liver failure, researchers demonstrate successful transplantation of fetal rat liver cells to an injured adult rat liver. (Source: ScienceDaily Headlines)
Categories: Publications

Consumer Health Tips: Liver transplantation

Tue, 04/25/2017 - 23:00
Liver transplant Liver transplantation usually is reserved for people who have significant complications due to end-stage chronic liver disease. In rare cases, sudden failure of a previously normal liver can occur. Learn more about the functions of the liver, the waiting list for available organs, and how to begin the process of signing up to [...] (Source: News from Mayo Clinic)

MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best Christmas presents too.

Categories: Publications

NASH: The Next Untapped Pharma Market Gives Investors Many Options NASH: The Next Untapped Pharma Market Gives Investors Many Options

Tue, 04/25/2017 - 19:20
Large drugmakers with piles of cash are on the hunt for promising medicines being developed by small companies to treat non-alcoholic steatohepatitis (NASH), a progressive fatty liver disease poised to become the leading cause of liver transplants by 2020.Reuters Health Information (Source: Medscape Transplantation Headlines)
Categories: Publications

NASH: The next untapped pharma market gives investors many options

Mon, 04/24/2017 - 11:09
(Reuters) - Large drugmakers with piles of cash are on the hunt for promising medicines being developed by small companies to treat NASH, a progressive fatty liver disease poised to become the leading cause of liver transplants by 2020. (Source: Reuters: Health)
Categories: Publications

How Common is α -1-Antitrypsin Deficiency?

Sun, 04/23/2017 - 23:32
Discussion α-1-Antitrypsin Deficiency (A1AT) is a common single-gene mutation disease that is homozygous recessive. The normal allele is called M and the most common abnormal allele is Z. There are other alleles though. The gene codes for one of the primary protease inhibitors in the serum, thus those who are homozygous for the Z gene are sometimes referred to as “PIZZ” or “PIZ.” α-1-Antitrypsin is found in all body tissues but is especially important in the serum and lung. As noted it is one of the primary neutrophil protease inhibitors in the serum, and acts to neutralize these enzymes when they leak into the extracellular fluid during inflammation. The Z mutation causes the synthesis of an abnormal protein which is retained in the hepatocytes and accu...
Categories: Publications

Pages